Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 70701-70750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06090578
TabCAT Brain Health Assessment in Primary Care
NARecruiting
180,000 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05884320
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
PHASE2Recruiting
30 participants
Started: Jul 27, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05895409
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
N/ARecruiting
610 participants
Started: Jul 27, 2023 · Completed: Jun 1, 2028
1 condition1 sponsor1 location
NCT05934331
A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study
PHASE2Recruiting
276 participants
Started: Jul 27, 2023 · Completed: Jul 1, 2028
1 condition1 sponsor1 location
NCT05777278
Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression
PHASE1/PHASE2Recruiting
29 participants
Started: Jul 26, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05907122
A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma
PHASE3Active, not recruiting
256 participants
Started: Jul 26, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor111 locations
NCT05924256
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
PHASE2Recruiting
88 participants
Started: Jul 26, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05895825
A Study of EOC237 in Patients With Advanced Solid Tumor
PHASE1Recruiting
48 participants
Started: Jul 26, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06204484
MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
NARecruiting
349 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06193057
Comparison of Customized and Standard Total Ankle Prostheses
NARecruiting
24 participants
Started: Jul 26, 2023 · Completed: Jul 26, 2026
1 condition1 sponsor1 location
NCT05982561
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
N/ARecruiting
500 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05878730
Melatonin and Response to Lithium
N/ARecruiting
60 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06315205
Evaluation of the Pharmacokinetics, Safety, and Tolerability of IM Letrozole LEBE in Healthy Post-menopausal Women
PHASE1Active, not recruiting
90 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05919290
HN-QUEST: A Study of Head and Neck Imaging Biomarkers
NARecruiting
173 participants
Started: Jul 26, 2023 · Completed: Jul 1, 2029
1 condition1 sponsor1 location
NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
PHASE2Recruiting
265 participants
Started: Jul 26, 2023 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT05935735
Feasibility of Brief Behavioral Therapy for Insomnia (BBTI) in SUD Recovery
NARecruiting
150 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05612178
A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy
PHASE1Recruiting
200 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05301348
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
NARecruiting
30 participants
Started: Jul 26, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05918692
A Phase 1, Study of BMF-500 in Adults With Acute Leukemia
PHASE1Recruiting
84 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor23 locations
NCT05972343
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
N/ARecruiting
100 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2031
2 conditions1 sponsor1 location
NCT05766631
Treating Polysubstance Use Using a Novel Digital Technology
PHASE3Recruiting
240 participants
Started: Jul 26, 2023 · Completed: Sep 29, 2027
4 conditions2 sponsors5 locations
NCT05696782
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
PHASE2Recruiting
28 participants
Started: Jul 26, 2023 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05924971
Aspirin for Postpartum Patients With Preeclampsia
PHASE2Recruiting
86 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05842070
The Stanford Egg Freezing Study
NAActive, not recruiting
100 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05849753
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
N/ARecruiting
50 participants
Started: Jul 26, 2023 · Completed: Mar 30, 2026
4 conditions2 sponsors2 locations
NCT05855811
PREventing Second Cancers With DOSTARlimab
PHASE2Recruiting
400 participants
Started: Jul 26, 2023 · Completed: Mar 26, 2029
3 conditions2 sponsors5 locations
NCT05783765
Food Genetics Behavior Study
NARecruiting
158 participants
Started: Jul 26, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05963217
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
PHASE1Recruiting
19 participants
Started: Jul 26, 2023 · Completed: May 30, 2026
3 conditions2 sponsors1 location
NCT06185335
A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Jul 26, 2023 · Completed: Jun 30, 2033
1 condition1 sponsor17 locations
NCT05970237
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
N/ARecruiting
9,000 participants
Started: Jul 26, 2023 · Completed: Oct 21, 2025
2 conditions1 sponsor1 location
NCT06078046
MOVIN' CARE for PD (Mind-body Interventions)
NAActive, not recruiting
154 participants
Started: Jul 26, 2023 · Completed: Jun 11, 2027
1 condition3 sponsors1 location
NCT05842785
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2Recruiting
162 participants
Started: Jul 26, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06147284
MOVIN' CARE for PD (Risk Management)
NAActive, not recruiting
308 participants
Started: Jul 26, 2023 · Completed: Jun 11, 2027
1 condition3 sponsors1 location
NCT06196190
Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
N/ARecruiting
200 participants
Started: Jul 26, 2023 · Completed: Jul 1, 2028
2 conditions1 sponsor1 location
NCT05931887
Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention
NARecruiting
200 participants
Started: Jul 26, 2023 · Completed: Jul 26, 2025
4 conditions1 sponsor1 location
NCT05779449
Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS
NARecruiting
100 participants
Started: Jul 26, 2023 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT05909267
Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
NARecruiting
165 participants
Started: Jul 26, 2023 · Completed: Oct 31, 2025
1 condition5 sponsors1 location
NCT04663152
Integrated Navigation Services for Treatment Adherence, Counseling, and Research
NARecruiting
10 participants
Started: Jul 26, 2023 · Completed: May 31, 2027
1 condition2 sponsors1 location
NCT05680922
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
PHASE1Recruiting
41 participants
Started: Jul 26, 2023 · Completed: Mar 31, 2028
2 conditions1 sponsor4 locations
NCT05694637
Botswana Smoking and Abstinence Reinforcement Trial
PHASE4Enrolling by invitation
750 participants
Started: Jul 25, 2023 · Completed: Aug 31, 2027
2 conditions4 sponsors10 locations
NCT05955261
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
PHASE2Recruiting
70 participants
Started: Jul 25, 2023 · Completed: Mar 31, 2034
1 condition2 sponsors9 locations
NCT06272617
Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
NARecruiting
138 participants
Started: Jul 25, 2023 · Completed: Jul 24, 2025
2 conditions2 sponsors1 location
NCT04677647
OurChild: A Health IT Solution to Reduce Minority Health Disparities
NARecruiting
254 participants
Started: Jul 25, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05798520
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
PHASE2Recruiting
275 participants
Started: Jul 25, 2023 · Completed: Sep 7, 2027
1 condition1 sponsor77 locations
NCT05510908
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
N/AActive, not recruiting
720 participants
Started: Jul 25, 2023 · Completed: Jul 31, 2025
8 conditions2 sponsors16 locations
NCT06983054
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
PHASE4Recruiting
34 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06981676
The Developmental Origins of Obesity
NARecruiting
160 participants
Started: Jul 25, 2023 · Completed: Mar 30, 2027
2 conditions1 sponsor1 location
NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 25, 2023 · Completed: Jul 24, 2026
10 conditions1 sponsor1 location
NCT05828810
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NARecruiting
400 participants
Started: Jul 25, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor3 locations
NCT05721937
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
N/ARecruiting
400 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location